(MENAFN- GlobeNewsWire - Nasdaq) itemprop="articleBody">
EASTPHARMA LTD.
London, 1 March 2019 - EastPharma (EAST LI) informs that it will be releasing its audited financial statements for the year ended 31 December 2018 and a review of its main subsidiary DEVA Holding's audited financial statements for the related period on 8 March 2019.
A conference call to review the financial performance for the year ended 31 December 2018 will be hosted by the management of EastPharma at 12:00-noon London time on 11 March 2019 (08:00am New York time / 01:00-pm Zurich time / 03:00pm Istanbul time). The dial-in details are provided below.
Conference call:
Dial-in Number (UK): +44 (0) 2071 928501
Dial-in Number (US): 19177200181
Dial-in Number (Switzerland): 0445806085
Dial-in Number (Germany): 030221533116
Conference ID: 4677714
For further information, please contact:
Investor Relations:
email:
EastPharma Ltd - a company active in the manufacturing and marketing of pharmaceutical products in Turkey and in other regional markets; for further information please visit www.eastpharma.com .
MENAFN0103201900703653ID1098192643
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.